Molecular cytogenetic analysis and clinical manifestations of a case with de novo mosaic ring chromosome 7
-
* Corresponding author: Ingrid Y Liu ycliu@mail.tcu.edu.tw
- Equal contributors
1 Department of Pediatrics, Buddhist Tzu Chi General Hospital, Taipei Branch, 289, Jianguo Rd., Sindian City, Taipei County 231, Taiwan
2 Department of Medicine, Tzu Chi University, 701, Sec 3, Chunyang Rd., Hualien 970, Taiwan
3 Laboratory for Cytogenetics, Centre for Genetic Counselling, Buddhist Tzu Chi Hospital, 701, Sec 3, Chunyang Rd., Hualien 970, Taiwan
4 Department of Molecular Biology and Human Genetics, Tzu Chi University, 701, Sec 3, Chunyang Rd., Hualien 970, Taiwan
Molecular Cytogenetics 2011, 4:5 doi:10.1186/1755-8166-4-5
Published: 8 February 2011Abstract
Aim
Clinical and molecular cytogenetic investigations of a newborn girl exhibiting facial dysmorphism with developmental delay.
Methods
Phenotypic evaluation was first applied to examine the proband's developmental status. Computed tomography and colour transcranial Doppler were used then to investigate her brain structure and function. Subsequently, chromosomal abnormalities were examined by karyotyping and fluorescent in situ hybridization was performed to investigate size of fragments lost at the two distal ends of the ring chromosome 7. In addition, multicolour banding was applied to rule out structural rearrangement occurs in between the ring chromosome 7.
Results
The proband was born with mosaic supernumerary ring chromosome 7, without a normal karyotype detected in the peripheral blood lymphocytes. The distal arm of chromosome 7p (at least 255 kb from the telomere) was part of an extra ring chromosome 7. In addition, the distal arm of 7q, at least 8 kb from the telomere, was missing. There was no other chromosomal rearrangement detected by multicolour banding.
Interpretation
This is the 19th reported case of complete ring chromosome 7 mosaicism and the first survived case with mosaic supernumerary ring 7 without a normal karyotype detected in the peripheral lymphocytes.